CRUK backs AI-powered, virtual radiotherapy trial projects
Cancer Research UK has provided £5.9 million ($7.7 million) in funding to a project that will explore the use of artificial intelligence in trials of radiotherapy treatments, as well as vir
Newsletters and Deep Dive digital magazine
Cancer Research UK has provided £5.9 million ($7.7 million) in funding to a project that will explore the use of artificial intelligence in trials of radiotherapy treatments, as well as vir
NHS England has started a pilot trial of an iPhone app and device combination that could be used by nursing staff to speed up reviews of suspected throat cancer.
Generic drugmaker Accord Healthcare has announced a £50 million ($65 million) investment in the UK that will include the construction of a new medicines manufacturing facility.
Investors in the cell therapy industry are actively looking into solid tumours, autoimmune indications and novel engineering as the best place to allocate their money and resources.
Implement State-of-the-Art, Reproducible & Predictive in vivo & in vitro Oncology Models to Successfully Identify Promising Targets & Biomarkers, & Surmount the Translationa
Editor's Picks
Newsletters and Deep Dive
digital magazine